Results 141 to 150 of about 2,874 (159)
Some of the next articles are maybe not open access.
Drugs, 2017
Relebactam (formerly known as MK-7655) is a non-β-lactam, bicyclic diazabicyclooctane, β-lactamase inhibitor that is structurally related to avibactam, differing by the addition of a piperidine ring to the 2-position carbonyl group. Vaborbactam (formerly known as RPX7009) is a non-β-lactam, cyclic, boronic acid-based, β-lactamase inhibitor.
George G, Zhanel +13 more
openaire +2 more sources
Relebactam (formerly known as MK-7655) is a non-β-lactam, bicyclic diazabicyclooctane, β-lactamase inhibitor that is structurally related to avibactam, differing by the addition of a piperidine ring to the 2-position carbonyl group. Vaborbactam (formerly known as RPX7009) is a non-β-lactam, cyclic, boronic acid-based, β-lactamase inhibitor.
George G, Zhanel +13 more
openaire +2 more sources
A molecular analysis of meropenem–vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae
Antimicrobial Agents and ChemotherapyABSTRACT We characterized the molecular determinants of meropenem–vaborbactam (MV) non-susceptibility among non-metallo-β-lactamase-producing KPC- Klebsiella pneumoniae (KPC- KP ).
Mohamad Yasmin +13 more
openaire +2 more sources
Delafloxacin meglumine, Meropenem trihydrate/vaborbactam, Secnidazole, and Benznidazole
Journal of the American Pharmacists Association, 2018Daniel A, Hussar, Molly A, Walter
openaire +2 more sources
Meropenem/vaborbactam cost effective in Italy
PharmacoEconomics & Outcomes News, 2021openaire +1 more source